SCHEMBL20174246

SCHEMBL20174246

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5ccc6c(c5)-c5ccccc5C65c6ccccc6-c6oc7ccccc7c65)cc4)n3)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.34
PLA2G4A P47712 4/20 0.34
MAPT P10636 5/20 0.34
KMT2A Q03164 5/20 0.34
LMNA P02545 3/20 0.34
TSHR P16473 2/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34
MEN1 O00255 4/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
EPHX2 P34913 1/20 0.33
KDM4E B2RXH2 3/20 0.33
ATM Q13315 2/20 0.33
TP53 P04637 2/20 0.33
MAPK1 P28482 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20174291 0.94 KMT2A (0.38) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174203 0.93 MAPT (0.33) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174240 0.92 KMT2A (0.41) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174229 0.92 MAPT (0.36) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174223 0.91 KMT2A (0.37) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174217 0.91 KMT2A (0.37) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174273 0.91 PDK2 (0.36) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL22326557 0.91 PDK2 (0.36) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174211 0.91 PDK2 (0.34) PLA2G2APLA2G4AMAPTKMT2ALMNA
SCHEMBL20174276 0.91 PLA2G2A (0.33) PLA2G2APLA2G4AMAPTKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738034-B2 Spiro compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2020-08-11 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738034-B2 Spiro compound and organic light-emitting device comprising same CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885MAPT 811/4885
US-20180141933-A1 SPIRO COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, NR2E3, ERG PLA2G2A 4788/4885PLA2G4A 4802/4885MAPT 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.